CoChat
Sign Up
Cited by 146

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

The BAP1/ASXL2 Histone H2A Deubiquitinase Complex Regulates Cell Proliferation and Is Disrupted in Cancer

Daou, Salima, Hammond-Martel, Ian, Mashtalir, Nazar, Barbour, Haithem, Gagnon, Jessica, Iannantuono, NicholasV.G., Nkwe, Nadine Sen, Motorina, Alena, Pak, Helen, Yu, Helen, Wurtele, Hugo, Milot, Eric, Mallette, Frédérick A., Carbone, Michele, Affar, El Bachir·2015·Journal of Biological Chemistry
DOI 10.1074/jbc.m115.661553
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m115.661553

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 61

  1. MacGurn, 2012, Ubiquitin and membrane protein turnover: from cradle to grave, Annu. Rev. Biochem, 81, 231, 10.1146/annurev-biochem-060210-093619 · DOI · Paper page
  2. Nakayama, 2006, Ubiquitin ligases: cell-cycle control and cancer, Nat. Rev. Cancer, 6, 369, 10.1038/nrc1881 · DOI
  3. Komander, 2012, The ubiquitin code, Annu. Rev. Biochem, 81, 203, 10.1146/annurev-biochem-060310-170328 · DOI · Paper page
  4. Hammond-Martel, 2012, Roles of ubiquitin signaling in transcription regulation, Cell. Signal, 24, 410, 10.1016/j.cellsig.2011.10.009 · DOI
  5. Jackson, 2013, Regulation of DNA damage responses by ubiquitin and SUMO, Mol. Cell, 49, 795, 10.1016/j.molcel.2013.01.017 · DOI · Paper page
  6. Metzger, 2012, HECT and RING finger families of E3 ubiquitin ligases at a glance, J. Cell Sci, 125, 531, 10.1242/jcs.091777 · DOI
  7. Reyes-Turcu, 2009, Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes, Annu. Rev. Biochem, 78, 363, 10.1146/annurev.biochem.78.082307.091526 · DOI · Paper page
  8. Eletr, 2014, Regulation of proteolysis by human deubiquitinating enzymes, Biochim. Biophys. Acta, 1843, 114, 10.1016/j.bbamcr.2013.06.027 · DOI
  9. Husnjak, 2012, Ubiquitin-binding proteins: decoders of ubiquitin-mediated cellular functions, Annu. Rev. Biochem, 81, 291, 10.1146/annurev-biochem-051810-094654 · DOI
  10. Murali, 2013, Tumours associated with BAP1 mutations, Pathology, 45, 116, 10.1097/PAT.0b013e32835d0efb · DOI
  11. Carbone, 2013, BAP1 and cancer, Nat. Rev. Cancer, 13, 153, 10.1038/nrc3459 · DOI · Paper page
  12. Jensen, 1998, BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression, Oncogene, 16, 1097, 10.1038/sj.onc.1201861 · DOI
  13. Harbour, 2010, Frequent mutation of BAP1 in metastasizing uveal melanomas, Science, 330, 1410, 10.1126/science.1194472 · DOI
  14. Abdel-Rahman, 2011, Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers, J. Med. Genet, 48, 856, 10.1136/jmedgenet-2011-100156 · DOI
  15. Goldstein, 2011, Germline BAP1 mutations and tumor susceptibility, Nat. Genet, 43, 925, 10.1038/ng.956 · DOI
  16. Testa, 2011, Germline BAP1 mutations predispose to malignant mesothelioma, Nat. Genet, 43, 1022, 10.1038/ng.912 · DOI · Paper page
  17. Wiesner, 2011, Germline mutations in BAP1 predispose to melanocytic tumors, Nat. Genet, 43, 1018, 10.1038/ng.910 · DOI
  18. Dey, 2012, Loss of the tumor suppressor BAP1 causes myeloid transformation, Science, 337, 1541, 10.1126/science.1221711 · DOI
  19. Pena-Llopis, 2012, BAP1 loss defines a new class of renal cell carcinoma, Nat. Genet, 44, 751, 10.1038/ng.2323 · DOI
  20. Ventii, 2008, BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization, Cancer Res, 68, 6953, 10.1158/0008-5472.CAN-08-0365 · DOI
  21. Misaghi, 2009, Association of C-terminal ubiquitin hydrolase BRCA1-associated protein 1 with cell cycle regulator host cell factor 1, Mol. Cell. Biol, 29, 2181, 10.1128/MCB.01517-08 · DOI
  22. Yu, 2014, Tumor suppressor and deubiquitinase BAP1 promotes DNA double-strand break repair, Proc. Natl. Acad. Sci. U.S.A, 111, 285, 10.1073/pnas.1309085110 · DOI
  23. Sowa, 2009, Defining the human deubiquitinating enzyme interaction landscape, Cell, 138, 389, 10.1016/j.cell.2009.04.042 · DOI
  24. Yu, 2010, The ubiquitin carboxyl hydrolase BAP1 forms a ternary complex with YY1 and HCF-1 and is a critical regulator of gene expression, Mol. Cell. Biol, 30, 5071, 10.1128/MCB.00396-10 · DOI
  25. Pan, 2015, BAP1 regulates cell cycle progression through E2F1 target genes and mediates transcriptional silencing via H2A monoubiquitination in uveal melanoma cells, Int. J. Biochem. Cell Biol, 60, 176, 10.1016/j.biocel.2015.01.001 · DOI
  26. Ismail, 2014, Germ-line mutations in BAP1 impair its function in DNA double-strand break repair, Cancer Res, 74, 4282, 10.1158/0008-5472.CAN-13-3109 · DOI
  27. Lee, 2014, Stabilization and targeting of INO80 to replication forks by BAP1 during normal DNA synthesis, Nat. Commun, 5, 5128, 10.1038/ncomms6128 · DOI
  28. Eletr, 2013, BAP1 is phosphorylated at serine 592 in S-phase following DNA damage, FEBS Lett, 587, 3906, 10.1016/j.febslet.2013.10.035 · DOI
  29. Mashtalir, 2014, Autodeubiquitination protects the tumor suppressor BAP1 from cytoplasmic sequestration mediated by the atypical ubiquitin ligase UBE2O, Mol. Cell, 54, 392, 10.1016/j.molcel.2014.03.002 · DOI
  30. Scheuermann, 2010, Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB, Nature, 465, 243, 10.1038/nature08966 · DOI · Paper page
  31. Wang, 2004, Role of histone H2A ubiquitination in Polycomb silencing, Nature, 431, 873, 10.1038/nature02985 · DOI · Paper page
  32. Milne, 1999, The additional sex combs gene of Drosophila is required for activation and repression of homeotic loci, and interacts specifically with Polycomb and super sex combs, Mol. Gen. Genet, 261, 753, 10.1007/s004380050018 · DOI
  33. Gildea, 2000, A screen for new trithorax group genes identified little imaginal discs, the Drosophila melanogaster homologue of human retinoblastoma binding protein 2, Genetics, 156, 645, 10.1093/genetics/156.2.645 · DOI
  34. Cho, 2006, Additional sex comb-like 1 (ASXL1), in cooperation with SRC-1, acts as a ligand-dependent coactivator for retinoic acid receptor, J. Biol. Chem, 281, 17588, 10.1074/jbc.M512616200 · DOI
  35. Lee, 2010, ASXL1 represses retinoic acid receptor-mediated transcription through associating with HP1 and LSD1, J. Biol. Chem, 285, 18, 10.1074/jbc.M109.065862 · DOI
  36. Park, 2011, Additional sex comb-like (ASXL) proteins 1 and 2 play opposite roles in adipogenesis via reciprocal regulation of peroxisome proliferator-activated receptor γ, J. Biol. Chem, 286, 1354, 10.1074/jbc.M110.177816 · DOI
  37. Abdel-Wahab, 2012, ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression, Cancer Cell, 22, 180, 10.1016/j.ccr.2012.06.032 · DOI
  38. Okino, 2015, BRCA1-associated protein 1 (BAP1) deubiquitinase antagonizes the ubiquitin-mediated activation of FoxK2 target genes, J. Biol. Chem, 290, 1580, 10.1074/jbc.M114.609834 · DOI
  39. Fisher, 2006, Characterization of Asxl1, a murine homolog of additional sex combs, and analysis of the Asx-like gene family, Gene, 369, 109, 10.1016/j.gene.2005.10.033 · DOI
  40. Yao, 2006, Proteasome recruitment and activation of the Uch37 deubiquitinating enzyme by Adrm1, Nat. Cell Biol, 8, 994, 10.1038/ncb1460 · DOI
  41. Qiu, 2006, hRpn13/ADRM1/GP110 is a novel proteasome subunit that binds the deubiquitinating enzyme, UCH37, EMBO J, 25, 5742, 10.1038/sj.emboj.7601450 · DOI
  42. Hamazaki, 2006, A novel proteasome interacting protein recruits the deubiquitinating enzyme UCH37 to 26S proteasomes, EMBO J, 25, 4524, 10.1038/sj.emboj.7601338 · DOI
  43. Sanchez-Pulido, 2012, A common ancestry for BAP1 and Uch37 regulators, Bioinformatics, 28, 1953, 10.1093/bioinformatics/bts319 · DOI
  44. Katoh, 2013, Functional and cancer genomics of ASXL family members, Br. J. Cancer, 109, 299, 10.1038/bjc.2013.281 · DOI
  45. Balasubramani, 2015, Cancer-associated ASXL1 mutations may act as gain-of-function mutations of the ASXL1-BAP1 complex, Nat. Commun, 6, 7307, 10.1038/ncomms8307 · DOI · Paper page
  46. Hammond-Martel, 2010, PI 3 kinase related kinases-independent proteolysis of BRCA1 regulates Rad51 recruitment during genotoxic stress in human cells, PLoS One, 5, e14027, 10.1371/journal.pone.0014027 · DOI
  47. Daou, 2011, Crosstalk between O-GlcNAcylation and proteolytic cleavage regulates the host cell factor-1 maturation pathway, Proc. Natl. Acad. Sci. U.S.A, 108, 2747, 10.1073/pnas.1013822108 · DOI
  48. Lee, 2007, Protein expression and intracellular localization of prostate apoptosis response-4 (Par-4) are associated with apoptosis induction in nasopharyngeal carcinoma cell lines, Cancer Lett, 257, 252, 10.1016/j.canlet.2007.08.004 · DOI
  49. Ji, 2014, The forkhead transcription factor FOXK2 acts as a chromatin targeting factor for the BAP1-containing histone deubiquitinase complex, Nucleic Acids Res, 42, 6232, 10.1093/nar/gku274 · DOI
  50. Belle, 2014, H2A-DUBbing the mammalian epigenome: expanding frontiers for histone H2A deubiquitinating enzymes in cell biology and physiology, Int. J. Biochem. Cell Biol, 50, 161, 10.1016/j.biocel.2014.03.004 · DOI
  51. Morrow, 2013, Stabilization of an unusual salt bridge in ubiquitin by the extra C-terminal domain of the proteasome-associated deubiquitinase UCH37 as a mechanism of its exo specificity, Biochemistry, 52, 3564, 10.1021/bi4003106 · DOI
  52. Sahtoe, 2015, Mechanism of UCH-L5 activation and inhibition by DEUBAD domains in RPN13 and INO80G, Mol. Cell, 57, 887, 10.1016/j.molcel.2014.12.039 · DOI
  53. VanderLinden, 2015, Structural basis for the activation and inhibition of the UCH37 deubiquitylase, Mol. Cell, 57, 901, 10.1016/j.molcel.2015.01.016 · DOI
  54. Nishikawa, 2009, BRCA1-associated protein 1 interferes with BRCA1/BARD1 RING heterodimer activity, Cancer Res, 69, 111, 10.1158/0008-5472.CAN-08-3355 · DOI
  55. Dietrich, 2007, Bypass of senescence by the Polycomb group protein CBX8 through direct binding to the INK4A-ARF locus, EMBO J, 26, 1637, 10.1038/sj.emboj.7601632 · DOI · Paper page
  56. Luis, 2011, Regulation of human epidermal stem cell proliferation and senescence requires Polycomb-dependent and -independent functions of Cbx4, Cell Stem Cell, 9, 233, 10.1016/j.stem.2011.07.013 · DOI · Paper page
  57. Wysocka, 2003, Human Sin3 deacetylase and trithorax-related Set1/Ash2 histone H3-K4 methyltransferase are tethered together selectively by the cell-proliferation factor HCF-1, Genes Dev, 17, 896, 10.1101/gad.252103 · DOI
  58. Tyagi, 2007, E2F activation of S phase promoters via association with HCF-1 and the MLL family of histone H3K4 methyltransferases, Mol. Cell, 27, 107, 10.1016/j.molcel.2007.05.030 · DOI
  59. Leung, 2004, Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas, Nature, 428, 337, 10.1038/nature02385 · DOI
  60. Xu, 2011, Overexpression of the EZH2, RING1 and BMI1 genes is common in myelodysplastic syndromes: relation to adverse epigenetic alteration and poor prognostic scoring, Ann. Hematol, 90, 643, 10.1007/s00277-010-1128-5 · DOI
  61. Bosch, 2014, The Polycomb group protein RING1B is overexpressed in ductal breast carcinoma and is required to sustain FAK steady state levels in breast cancer epithelial cells, Oncotarget, 5, 2065, 10.18632/oncotarget.1779 · DOI

Cited by

Metadata

Authors
Daou, S., Hammond-Martel, I., Mashtalir, N., Barbour, H., Gagnon, J., Iannantuono, N. G., Nkwe, N. S., Motorina, A., Pak, H., Yu, H., Wurtele, H., Milot, E., Mallette, F. A., Carbone, M., & Affar, E. B.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2015-11
Volume
290
Issue
48
Pages
28643-28663
ISSN
0021-9258
DOI
10.1074/jbc.m115.661553
Cited by
146
References
4
Language
en
Licence
Funders
  • Canadian Institutes of Health Research (MOP-115132, MOP-133442)
  • Natural Sciences and Engineering Research Council of Canada (355814–2010)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review